RA Capital Management - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 73 filers reported holding G1 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
RA Capital Management ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$14,839,000
+146.2%
483,990
+33.3%
0.80%
+206.5%
Q1 2019$6,027,000
+246.8%
363,051
+807.6%
0.26%
+130.1%
Q2 2018$1,738,000
+17.3%
40,0000.0%0.11%
-0.9%
Q1 2018$1,482,000
-53.2%
40,000
-75.0%
0.11%
-57.0%
Q4 2017$3,170,000
-93.6%
159,780
-94.0%
0.26%
-94.1%
Q3 2017$49,793,000
+6.4%
2,684,2440.0%4.50%
-16.3%
Q2 2017$46,813,0002,684,2445.37%
Other shareholders
G1 THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Birchview Capital, LP 120,000$172,8000.15%
DENALI ADVISORS LLC 148,800$214,2720.08%
XTX Topco Ltd 296,601$427,1050.07%
NEEDHAM INVESTMENT MANAGEMENT LLC 234,000$336,9600.06%
LEVEL FOUR ADVISORY SERVICES, LLC 183,400$264,0960.02%
Curi Wealth Management, LLC 70,742$101,8690.02%
FRANKLIN STREET ADVISORS INC /NC 83,400$1200.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 140,000$201,6000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 573,256$825,4890.01%
ALGERT GLOBAL LLC 68,100$980.01%
View complete list of G1 THERAPEUTICS INC shareholders